Study #ECOG-ACRINEA8171
ECOG-ACRINEA8171: Multiparametric MRI (mpMRI) for Preoperative Staging and Treatment Planning for Newly-Diagnosed Prostate Cancer
MD Anderson Study Status
Not Accepting
Treatment Agent
Diagnostic Test: Multiparametric Magnetic Resonance Imaging
Description
This phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate cancer. Multiparametric MRI may be useful for evaluating the type of cancer in finding aggressive disease.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Prostate Carcinoma
Study phase:
Not applicable
Physician name:
Tharakeswara Bathala
Department:
Abdominal Imaging Department
For general questions about clinical trials:
1-855-508-2908
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.